Idecabtagene vicleucel versus ciltacabtagene autoleucel: a Sophie’s choice for patients with relapsed refractory multiple myeloma
James A. Davis, Mary McGann, Abigail Shockley, Hamza Hashmi
Topics & Concepts
MedicineMultiple myelomaRefractory (planetary science)CarfilzomibOncologyInternal medicineLenalidomideAstrobiologyPhysicsMultiple Myeloma Research and TreatmentsCAR-T cell therapy researchProtein Degradation and Inhibitors